Gunther Birznieks - 26 Aug 2022 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role
SVP, Business Development
Signature
/s/ Gunther Birznieks
Issuer symbol
VNDA
Transactions as of
26 Aug 2022
Net transactions value
+$3,900
Form type
4
Filing time
29 Aug 2022, 17:02:39 UTC
Previous filing
02 Mar 2022
Next filing
21 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNDA Common Stock Options Exercise $3,900 +1,250 +0.66% $3.12 190,057 26 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VNDA Employee Stock Option (Right to Buy) Options Exercise $0 -1,250 -100% $0.000000* 0 26 Aug 2022 Common Stock 1,250 $3.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in 48 equal monthly installments beginning on December 7, 2012.